Status:
COMPLETED
Corneal Uptake of Riboflavin Eye Drops
Lead Sponsor:
Luzerner Kantonsspital
Conditions:
Keratoconus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall objective of this study is to optimise the corneal cross-linking standard protocol in terms of a more economical use of the resource "medical personnel" and in terms of increased patient p...
Detailed Description
This national single-centre, experimental, randomized and controlled trial will comprise two parallel arms. The intervention to be studied will be an alternative application of riboflavin drops in the...
Eligibility Criteria
Inclusion
- Healthy clinical staff members of the Dept. of Ophthalmology at the Lucerne Cantonal Hospital will be evaluated for study inclusion.
- Signed written informed consent form
Exclusion
- Aged \< 18 years
- Any ocular or systemic diseases with ocular side effects
- Medication with potential ocular side effects
- Epilepsia, due to the flickering light of the fluorophotometer used to measure anterior chamber riboflavin concentration
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04062435
Start Date
December 1 2019
End Date
March 1 2020
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Ophthalmology, Lucerne Cantonal Hospital
Lucerne, Switzerland, 6004